
=== FINAL SUMMARY ===

**One-sentence overview:** The financial performance for Continuing Operations showed a decrease in operating revenue, EBITDA, EBIT, and NPAT, while Reported Results and Underlying metrics demonstrated significant improvements in several areas.

1. Operating revenue for Continuing Operations decreased by 13% from 176931 to 154159.
2. Gross profit for Continuing Operations increased by 17% from 45139 to 52963.
3. EBITDA for Continuing Operations decreased by 34% from 10878 to 7202.
4. EBIT for Continuing Operations decreased by 174% from 1405 to (1040).
5. NPAT for Continuing Operations decreased by 284% from 1089 to (2003).
6. Operating revenue for Reported Results decreased by 13% from 178139 to 154585.
7. Gross profit for Reported Results increased by 16% from 45944 to 53225.
8. EBITDA for Reported Results increased by 206% from (5700) to 6062.
9. EBIT for Reported Results increased by 85% from (15278) to (2252).
10. NPAT for Reported Results increased by 72% from (15640) to (4360).
11. EPS (cents) for Reported Results increased by 76% from (7.0) to (1.7).
12. Underlying EBITDA2 increased by 45% from 15739 to 22866.
13. Underlying EBIT2 increased by 77% from 8537 to 15151.
14. Underlying NPAT2 increased by 64% from 6732 to 11062.
15. Underlying EPS2 increased by 65% from 3.1 to 5.1.

Answer Echoes:
- "Operating revenue for Continuing Operations decreased by 13% from 176,931 to 154,159."
- "Gross profit for Continuing Operations increased by 17% from 45,139 to 52,963."
- "EBITDA for Continuing Operations decreased by 34% from 10,878 to 7,202."
- "EBIT for Continuing Operations decreased by 174% from 1,405 to (1,040)."
- "NPAT for Continuing Operations decreased by 284% from 1,089 to (2,003)."
- "Operating revenue for Reported Results decreased by 13% from 178,139 to 154,585."
- "Gross profit for Reported Results increased by 16% from 45,944 to 53,225."
- "EBITDA for Reported Results increased by 206% from (5,700) to 6,062."
- "EBIT for Reported Results increased by 85% from (15,278) to (2,252)."
- "NPAT for Reported Results increased by 72% from (15,640) to (4,360)."
- "EPS (cents) for Reported Results increased by 76% from (7.0) to (1.7)."
- "Underlying EBITDA2 increased by 45% from 15,739 to 22,866."
- "Underlying EBIT2 increased by 77% from 8,537 to 15,151."
- "Underlying NPAT2 increased by 64% from 6,732 to 11,062."
- "Underlying EPS2 increased by 65% from 3.1 to 5.1."

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': "1. Compare 'Operating revenue' for Continuing "
                      'Operations between 2019 and 2018 to observe the '
                      'change.\n'
                      "2. Compare 'Gross profit' for Continuing Operations "
                      'between 2019 and 2018 to observe the change.\n'
                      "3. Compare 'EBITDA' for Continuing Operations between "
                      '2019 and 2018 to observe the change.\n'
                      "4. Compare 'EBIT' for Continuing Operations between "
                      '2019 and 2018 to observe the change.\n'
                      "5. Compare 'NPAT' for Continuing Operations between "
                      '2019 and 2018 to observe the change.\n'
                      "6. Compare 'Operating revenue' for Reported Results "
                      'between 2019 and 2018 to observe the change.\n'
                      "7. Compare 'Gross profit' for Reported Results between "
                      '2019 and 2018 to observe the change.\n'
                      "8. Compare 'EBITDA' for Reported Results between 2019 "
                      'and 2018 to observe the change.\n'
                      "9. Compare 'EBIT' for Reported Results between 2019 and "
                      '2018 to observe the change.\n'
                      "10. Compare 'NPAT' for Reported Results between 2019 "
                      'and 2018 to observe the change.\n'
                      "11. Compare 'EPS (cents)' for Reported Results between "
                      '2019 and 2018 to observe the change.\n'
                      "12. Compare 'Underlying EBITDA2' between 2019 and 2018 "
                      'to observe the change.\n'
                      "13. Compare 'Underlying EBIT2' between 2019 and 2018 to "
                      'observe the change.\n'
                      "14. Compare 'Underlying NPAT2' between 2019 and 2018 to "
                      'observe the change.\n'
                      "15. Compare 'Underlying EPS2' between 2019 and 2018 to "
                      'observe the change.',
               'result': '[TREND] Operating revenue for Continuing Operations '
                         'decreased by 13% from 176,931 to 154,159.\n'
                         '[TREND] Gross profit for Continuing Operations '
                         'increased by 17% from 45,139 to 52,963.\n'
                         '[TREND] EBITDA for Continuing Operations decreased '
                         'by 34% from 10,878 to 7,202.\n'
                         '[ANOMALY] EBIT for Continuing Operations decreased '
                         'by 174% from 1,405 to (1,040).\n'
                         '[ANOMALY] NPAT for Continuing Operations decreased '
                         'by 284% from 1,089 to (2,003).\n'
                         '[TREND] Operating revenue for Reported Results '
                         'decreased by 13% from 178,139 to 154,585.\n'
                         '[TREND] Gross profit for Reported Results increased '
                         'by 16% from 45,944 to 53,225.\n'
                         '[ANOMALY] EBITDA for Reported Results increased by '
                         '206% from (5,700) to 6,062.\n'
                         '[TREND] EBIT for Reported Results increased by 85% '
                         'from (15,278) to (2,252).\n'
                         '[TREND] NPAT for Reported Results increased by 72% '
                         'from (15,640) to (4,360).\n'
                         '[TREND] EPS (cents) for Reported Results increased '
                         'by 76% from (7.0) to (1.7).\n'
                         '[TREND] Underlying EBITDA2 increased by 45% from '
                         '15,739 to 22,866.\n'
                         '[TREND] Underlying EBIT2 increased by 77% from 8,537 '
                         'to 15,151.\n'
                         '[TREND] Underlying NPAT2 increased by 64% from 6,732 '
                         'to 11,062.\n'
                         '[TREND] Underlying EPS2 increased by 65% from 3.1 to '
                         '5.1.',
               'raw': '{\n'
                      '  "reasoning": "1. Compare \'Operating revenue\' for '
                      'Continuing Operations between 2019 and 2018 to observe '
                      "the change.\\n2. Compare 'Gross profit' for Continuing "
                      'Operations between 2019 and 2018 to observe the '
                      "change.\\n3. Compare 'EBITDA' for Continuing Operations "
                      'between 2019 and 2018 to observe the change.\\n4. '
                      "Compare 'EBIT' for Continuing Operations between 2019 "
                      "and 2018 to observe the change.\\n5. Compare 'NPAT' for "
                      'Continuing Operations between 2019 and 2018 to observe '
                      "the change.\\n6. Compare 'Operating revenue' for "
                      'Reported Results between 2019 and 2018 to observe the '
                      "change.\\n7. Compare 'Gross profit' for Reported "
                      'Results between 2019 and 2018 to observe the '
                      "change.\\n8. Compare 'EBITDA' for Reported Results "
                      'between 2019 and 2018 to observe the change.\\n9. '
                      "Compare 'EBIT' for Reported Results between 2019 and "
                      "2018 to observe the change.\\n10. Compare 'NPAT' for "
                      'Reported Results between 2019 and 2018 to observe the '
                      "change.\\n11. Compare 'EPS (cents)' for Reported "
                      'Results between 2019 and 2018 to observe the '
                      "change.\\n12. Compare 'Underlying EBITDA2' between 2019 "
                      'and 2018 to observe the change.\\n13. Compare '
                      "'Underlying EBIT2' between 2019 and 2018 to observe the "
                      "change.\\n14. Compare 'Underlying NPAT2' between 2019 "
                      'and 2018 to observe the change.\\n15. Compare '
                      "'Underlying EPS2' between 2019 and 2018 to observe the "
                      'change.",\n'
                      '  "bullets": [\n'
                      '    "[TREND] Operating revenue for Continuing '
                      'Operations decreased by 13% from 176,931 to 154,159.",\n'
                      '    "[TREND] Gross profit for Continuing Operations '
                      'increased by 17% from 45,139 to 52,963.",\n'
                      '    "[TREND] EBITDA for Continuing Operations decreased '
                      'by 34% from 10,878 to 7,202.",\n'
                      '    "[ANOMALY] EBIT for Continuing Operations decreased '
                      'by 174% from 1,405 to (1,040).",\n'
                      '    "[ANOMALY] NPAT for Continuing Operations decreased '
                      'by 284% from 1,089 to (2,003).",\n'
                      '    "[TREND] Operating revenue for Reported Results '
                      'decreased by 13% from 178,139 to 154,585.",\n'
                      '    "[TREND] Gross profit for Reported Results '
                      'increased by 16% from 45,944 to 53,225.",\n'
                      '    "[ANOMALY] EBITDA for Reported Results increased by '
                      '206% from (5,700) to 6,062.",\n'
                      '    "[TREND] EBIT for Reported Results increased by 85% '
                      'from (15,278) to (2,252).",\n'
                      '    "[TREND] NPAT for Reported Results increased by 72% '
                      'from (15,640) to (4,360).",\n'
                      '    "[TREND] EPS (cents) for Reported Results increased '
                      'by 76% from (7.0) to (1.7).",\n'
                      '    "[TREND] Underlying EBITDA2 increased by 45% from '
                      '15,739 to 22,866.",\n'
                      '    "[TREND] Underlying EBIT2 increased by 77% from '
                      '8,537 to 15,151.",\n'
                      '    "[TREND] Underlying NPAT2 increased by 64% from '
                      '6,732 to 11,062.",\n'
                      '    "[TREND] Underlying EPS2 increased by 65% from 3.1 '
                      'to 5.1."\n'
                      '  ]\n'
                      '}'},
 'Contextron': {'cot': 'The TABLE CONTEXT provides detailed financial trends '
                       'and anomalies for both Continuing Operations and '
                       'Reported Results, as well as Underlying Results. The '
                       'CONTEXT offers a description of the principal '
                       'activities and the nature of financial metrics used, '
                       'such as EBITDA and EBIT, but does not provide specific '
                       'figures. For each question, I reviewed the TABLE '
                       'CONTEXT to identify any missing data and then '
                       'cross-referenced the CONTEXT for additional '
                       'qualitative information. The TABLE CONTEXT '
                       'sufficiently answers the questions regarding financial '
                       'trends and anomalies, while the CONTEXT provides '
                       'background on the metrics used. Here are the extracted '
                       'evidence snippets:',
                'result': '- "Operating revenue for Continuing Operations '
                          'decreased by 13% from 176,931 to 154,159."\n'
                          '- "Gross profit for Continuing Operations increased '
                          'by 17% from 45,139 to 52,963."\n'
                          '- "EBITDA for Continuing Operations decreased by '
                          '34% from 10,878 to 7,202."\n'
                          '- "EBIT for Continuing Operations decreased by 174% '
                          'from 1,405 to (1,040)."\n'
                          '- "NPAT for Continuing Operations decreased by 284% '
                          'from 1,089 to (2,003)."\n'
                          '- "Operating revenue for Reported Results decreased '
                          'by 13% from 178,139 to 154,585."\n'
                          '- "Gross profit for Reported Results increased by '
                          '16% from 45,944 to 53,225."\n'
                          '- "EBITDA for Reported Results increased by 206% '
                          'from (5,700) to 6,062."\n'
                          '- "EBIT for Reported Results increased by 85% from '
                          '(15,278) to (2,252)."\n'
                          '- "NPAT for Reported Results increased by 72% from '
                          '(15,640) to (4,360)."\n'
                          '- "EPS (cents) for Reported Results increased by '
                          '76% from (7.0) to (1.7)."\n'
                          '- "Underlying EBITDA2 increased by 45% from 15,739 '
                          'to 22,866."\n'
                          '- "Underlying EBIT2 increased by 77% from 8,537 to '
                          '15,151."\n'
                          '- "Underlying NPAT2 increased by 64% from 6,732 to '
                          '11,062."\n'
                          '- "Underlying EPS2 increased by 65% from 3.1 to '
                          '5.1."',
                'raw': 'The TABLE CONTEXT provides detailed financial trends '
                       'and anomalies for both Continuing Operations and '
                       'Reported Results, as well as Underlying Results. The '
                       'CONTEXT offers a description of the principal '
                       'activities and the nature of financial metrics used, '
                       'such as EBITDA and EBIT, but does not provide specific '
                       'figures. For each question, I reviewed the TABLE '
                       'CONTEXT to identify any missing data and then '
                       'cross-referenced the CONTEXT for additional '
                       'qualitative information. The TABLE CONTEXT '
                       'sufficiently answers the questions regarding financial '
                       'trends and anomalies, while the CONTEXT provides '
                       'background on the metrics used. Here are the extracted '
                       'evidence snippets:\n'
                       '\n'
                       '- "Operating revenue for Continuing Operations '
                       'decreased by 13% from 176,931 to 154,159."\n'
                       '- "Gross profit for Continuing Operations increased by '
                       '17% from 45,139 to 52,963."\n'
                       '- "EBITDA for Continuing Operations decreased by 34% '
                       'from 10,878 to 7,202."\n'
                       '- "EBIT for Continuing Operations decreased by 174% '
                       'from 1,405 to (1,040)."\n'
                       '- "NPAT for Continuing Operations decreased by 284% '
                       'from 1,089 to (2,003)."\n'
                       '- "Operating revenue for Reported Results decreased by '
                       '13% from 178,139 to 154,585."\n'
                       '- "Gross profit for Reported Results increased by 16% '
                       'from 45,944 to 53,225."\n'
                       '- "EBITDA for Reported Results increased by 206% from '
                       '(5,700) to 6,062."\n'
                       '- "EBIT for Reported Results increased by 85% from '
                       '(15,278) to (2,252)."\n'
                       '- "NPAT for Reported Results increased by 72% from '
                       '(15,640) to (4,360)."\n'
                       '- "EPS (cents) for Reported Results increased by 76% '
                       'from (7.0) to (1.7)."\n'
                       '- "Underlying EBITDA2 increased by 45% from 15,739 to '
                       '22,866."\n'
                       '- "Underlying EBIT2 increased by 77% from 8,537 to '
                       '15,151."\n'
                       '- "Underlying NPAT2 increased by 64% from 6,732 to '
                       '11,062."\n'
                       '- "Underlying EPS2 increased by 65% from 3.1 to 5.1."'},
 'SummaCraft': {'cot': '(omitted)',
                'result': '**One-sentence overview:** The financial '
                          'performance for Continuing Operations showed a '
                          'decrease in operating revenue, EBITDA, EBIT, and '
                          'NPAT, while Reported Results and Underlying metrics '
                          'demonstrated significant improvements in several '
                          'areas.\n'
                          '\n'
                          '1. Operating revenue for Continuing Operations '
                          'decreased by 13% from 176931 to 154159.\n'
                          '2. Gross profit for Continuing Operations increased '
                          'by 17% from 45139 to 52963.\n'
                          '3. EBITDA for Continuing Operations decreased by '
                          '34% from 10878 to 7202.\n'
                          '4. EBIT for Continuing Operations decreased by 174% '
                          'from 1405 to (1040).\n'
                          '5. NPAT for Continuing Operations decreased by 284% '
                          'from 1089 to (2003).\n'
                          '6. Operating revenue for Reported Results decreased '
                          'by 13% from 178139 to 154585.\n'
                          '7. Gross profit for Reported Results increased by '
                          '16% from 45944 to 53225.\n'
                          '8. EBITDA for Reported Results increased by 206% '
                          'from (5700) to 6062.\n'
                          '9. EBIT for Reported Results increased by 85% from '
                          '(15278) to (2252).\n'
                          '10. NPAT for Reported Results increased by 72% from '
                          '(15640) to (4360).\n'
                          '11. EPS (cents) for Reported Results increased by '
                          '76% from (7.0) to (1.7).\n'
                          '12. Underlying EBITDA2 increased by 45% from 15739 '
                          'to 22866.\n'
                          '13. Underlying EBIT2 increased by 77% from 8537 to '
                          '15151.\n'
                          '14. Underlying NPAT2 increased by 64% from 6732 to '
                          '11062.\n'
                          '15. Underlying EPS2 increased by 65% from 3.1 to '
                          '5.1.\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- "Operating revenue for Continuing Operations '
                          'decreased by 13% from 176,931 to 154,159."\n'
                          '- "Gross profit for Continuing Operations increased '
                          'by 17% from 45,139 to 52,963."\n'
                          '- "EBITDA for Continuing Operations decreased by '
                          '34% from 10,878 to 7,202."\n'
                          '- "EBIT for Continuing Operations decreased by 174% '
                          'from 1,405 to (1,040)."\n'
                          '- "NPAT for Continuing Operations decreased by 284% '
                          'from 1,089 to (2,003)."\n'
                          '- "Operating revenue for Reported Results decreased '
                          'by 13% from 178,139 to 154,585."\n'
                          '- "Gross profit for Reported Results increased by '
                          '16% from 45,944 to 53,225."\n'
                          '- "EBITDA for Reported Results increased by 206% '
                          'from (5,700) to 6,062."\n'
                          '- "EBIT for Reported Results increased by 85% from '
                          '(15,278) to (2,252)."\n'
                          '- "NPAT for Reported Results increased by 72% from '
                          '(15,640) to (4,360)."\n'
                          '- "EPS (cents) for Reported Results increased by '
                          '76% from (7.0) to (1.7)."\n'
                          '- "Underlying EBITDA2 increased by 45% from 15,739 '
                          'to 22,866."\n'
                          '- "Underlying EBIT2 increased by 77% from 8,537 to '
                          '15,151."\n'
                          '- "Underlying NPAT2 increased by 64% from 6,732 to '
                          '11,062."\n'
                          '- "Underlying EPS2 increased by 65% from 3.1 to '
                          '5.1."',
                'raw': '**One-sentence overview:** The financial performance '
                       'for Continuing Operations showed a decrease in '
                       'operating revenue, EBITDA, EBIT, and NPAT, while '
                       'Reported Results and Underlying metrics demonstrated '
                       'significant improvements in several areas.\n'
                       '\n'
                       '1. Operating revenue for Continuing Operations '
                       'decreased by 13% from 176,931 to 154,159.\n'
                       '2. Gross profit for Continuing Operations increased by '
                       '17% from 45,139 to 52,963.\n'
                       '3. EBITDA for Continuing Operations decreased by 34% '
                       'from 10,878 to 7,202.\n'
                       '4. EBIT for Continuing Operations decreased by 174% '
                       'from 1,405 to (1,040).\n'
                       '5. NPAT for Continuing Operations decreased by 284% '
                       'from 1,089 to (2,003).\n'
                       '6. Operating revenue for Reported Results decreased by '
                       '13% from 178,139 to 154,585.\n'
                       '7. Gross profit for Reported Results increased by 16% '
                       'from 45,944 to 53,225.\n'
                       '8. EBITDA for Reported Results increased by 206% from '
                       '(5,700) to 6,062.\n'
                       '9. EBIT for Reported Results increased by 85% from '
                       '(15,278) to (2,252).\n'
                       '10. NPAT for Reported Results increased by 72% from '
                       '(15,640) to (4,360).\n'
                       '11. EPS (cents) for Reported Results increased by 76% '
                       'from (7.0) to (1.7).\n'
                       '12. Underlying EBITDA2 increased by 45% from 15,739 to '
                       '22,866.\n'
                       '13. Underlying EBIT2 increased by 77% from 8,537 to '
                       '15,151.\n'
                       '14. Underlying NPAT2 increased by 64% from 6,732 to '
                       '11,062.\n'
                       '15. Underlying EPS2 increased by 65% from 3.1 to 5.1.'}}
